Company · CIK 0000886982 · SIC 6211 — Security Brokers, Dealers & Flotation Companies · NYSE
GOLDMAN SACHS GROUP INC · GS
Insider activity reported against this company. All insider holders · Files at: ATTO, QVCGP, APUR, BNFT, ENLC, ENLK, COLD, GSBD and 16 more. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 SForm 4 → | Sep 1, 4:04 pm EDT | Ericka T LeslieChief Administrative Officer | 600 | $1,033.80 | $620,280 | 10,960 | −5.19% | |
| Aug 4, 2026 SForm 4 → | Aug 6, 4:04 pm EDT | Ericka T LeslieChief Administrative Officer | 175 | $1,053.97 | $184,445 | 11,560 | −1.49% | |
| Jul 15, 2026 GForm 4 → | Jul 17, 4:04 pm EDT | David A ViniarDirector | 2,000 | — | — | 548,000 | — | |
| Jul 15, 2026 SForm 4 → | Jul 17, 4:04 pm EDT | Ericka T LeslieChief Administrative Officer | 250 | $1,151.80 | $287,951 | 11,735 | −2.09% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 AForm 4 → | Jul 17, 4:04 pm EDT | Mark A. FlahertyDirector | 22 | — | — | 5,270 | — | |
| Jul 15, 2026 AForm 4 → | Jul 17, 4:04 pm EDT | John B HessDirector | 22 | — | — | 892 | — | |
| Jul 15, 2026 AForm 4 → | Jul 17, 4:04 pm EDT | Kevin R JohnsonDirector | 33 | — | — | 3,119 | — | |
| Jul 15, 2026 AForm 4 → | Jul 17, 4:04 pm EDT | Peter OppenheimerDirector | 50 | — | — | 7,342 | — |
Filed by this entity as an insider elsewhere — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 CForm 4/A → | Aug 28, 5:38 pm EDT | Attovia Therapeutics, Inc.ATTO | 2,435,632 | — | — | 2,520,632 | — | |
| Aug 6, 2026 CForm 4 → | Aug 13, 9:51 pm EDT | Attovia Therapeutics, Inc.ATTO | 2,435,632 | — | — | 2,520,632 | — | late amended |
| Aug 5, 2026 SForm 4/A → | Aug 28, 5:38 pm EDT | Attovia Therapeutics, Inc.ATTO | 105,807 | $21.28 | $2,251,658 | 0 | −100% | |
| Aug 5, 2026 PForm 4/A → | Aug 28, 5:38 pm EDT | Attovia Therapeutics, Inc.ATTO | 585,000 | $17.58 | $10,285,000 | 3,020,632 | +24.0% | |
| Aug 5, 2026 SForm 4 → | Aug 13, 9:51 pm EDT | Attovia Therapeutics, Inc.ATTO | 105,807 | $21.28 | $2,251,658 | 0 | −100% | late amended |
| Aug 5, 2026 PForm 4 → | Aug 13, 9:51 pm EDT | Attovia Therapeutics, Inc.ATTO | 585,000 | $17.58 | $10,285,000 | 3,020,632 | +24.0% | late amended |
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 CForm 4 → | Aug 13, 9:51 pm EDT | Attovia Therapeutics, Inc.ATTO | 22,627,105 | — | — | 0 | — | late amended |
| Aug 5, 2026 CPForm 4/A → | Aug 28, 5:38 pm EDT | Attovia Therapeutics, Inc.ATTO | 22,732,912 | $21.25 | $2,248,074 | 105,807 | — |